CAS NO: | 34661-75-1 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | Urapidil is anα1 adrenoreceptorantagonist and a5-HT1Areceptoragonist. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | Urapidil is an α1 adrenoreceptor antagonist and a 5-HT1Areceptor agonist. Urapidil does not affect vascular tone at concentrations up to 10-5M. Urapidil (10-5M) markedly inhibits the alpha 1-adrenergic agonist (phenylephrine)-induced concentration-dependent contractions in aortic rings without endothelium and also to some extent in those with endothelium. Moreover, the inhibitory effect of Urapidil is more pronounced in rings without endothelium than in those with endothelium. Urapidil (10-5M) affects neither the vascular tone nor the concentration-dependent contraction to serotonin[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 387.48 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C20H29N5O3 | ||||||||||||||||
CAS 号 | 34661-75-1 | ||||||||||||||||
中文名称 | 乌拉地尔 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 25 mg/mL(64.52 mM;Need ultrasonic) H2O : 0.1 mg/mL(0.26 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|